0
Sign In  | Subscribe
Please Wait... Processing your request... Please Wait.

Multiple Sclerosis Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Therapeutics |  May/Jun 2002
Review: In relapsing-remitting multiple sclerosis, recombinant interferon reduces exacerbations in the first 2 treatment years
PDFPDF
Jock Murray, MD
Ann Intern Med. 2002;136(3):104. doi:10.7326/ACPJC-2002-136-3-104
Book Notes |  1 October 1991
Handbook of Multiple Sclerosis
PDFPDF
Ann Intern Med. 1991;115(7):583. doi:10.7326/0003-4819-115-7-583_3
Diagnosis and Treatment |  1 July 1986
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
PDFPDF
TODD D. SHENKENBERG, M.D.; DANIEL D. VON HOFF, M.D.
Ann Intern Med. 1986;105(1):67-81. doi:10.7326/0003-4819-105-1-67
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than intramuscular interferon for relapsing–remitting multiple sclerosis
PDFPDF
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-6. doi:10.7326/0003-4819-152-10-201005180-02006
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than placebo for relapsing–remitting multiple sclerosis
PDFPDF
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-7. doi:10.7326/0003-4819-152-10-201005180-02007
ACP Journal Club |  18 May 2010
Oral cladribine was more effective than placebo for relapsing–remitting multiple sclerosis
PDFPDF
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-8. doi:10.7326/0003-4819-152-10-201005180-02008
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)